Copy Number Variation and Epilepsy: State of the Art in the Era of High-Throughput Sequencing-A Multicenter Cohort Study.
Sarah BaerAudrey SchalkMarguerite MiguetÉlise SchaeferSalima El ChehadehEmmanuelle GinglingerAnne de Saint MartinMarie-Thérèse Abi WardéVincent LaugelYvan de FeraudyLucas GauerEdouard HirschClotilde BoulayClaire BanseptAnamaria BolocanIsmini KitadinisAurélie GouroncBénédicte GérardAmélie PitonSophie ScheideckerPublished in: Pediatric neurology (2024)
CMA remains a viable option as the first-line genetic test in cases where other genetic tests are not available and as a second-line diagnostic technique if gene panel or exome sequencing yields negative results.